Mycronic develops, manufactures, and markets high-precision production equipment for the electronics industry. The company’s product areas include PCB assembly, photomask equipment, dispensing and coating, bare board testing, and die bonding. Mycronic provides solutions for manufacturing advanced displays, semiconductors, medical devices, and mobile phones. The company serves customers in Europe, North America, and Asia, with a global service network. Recent acquisitions include Hprobe, RoBat, and Surfx Technologies. Mycronic operates through divisions focused on these specific production technologies, supporting high-mix manufacturing and flexible production lines.

Summarised from the company's own disclosures, fiscal year ended Dec 2025

Industry Specialty Industrial Machinery Homepage mycronic.com
Sector Industrials IR page mycronic.com
Tags
pcb assembly, photomask equipment, dispensing, coating, bare board testing, die bonding, electronics manufacturing, semiconductor equipment, display manufacturing, high-mix manufacturing, Hprobe, RoBat, Surfx Technologies, SLX mask writers
Press page mycronic.com/sv/nyheter-event/pressmeddelanden

Metrics

Valuation  
Market cap kr 64.821B
Market cap (USD) $ 6.38B
P/E 25.10
PEG 0.89
P/BV 9.09
P/S 8.17
P/OCF 46.07
P/FCF —
Dividend yield 0.83%
Turnover / mcap —
Returns  
ROE 22.8%
ROI 21.9%
ROIC 21.6%
Profit margin 19.7%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) 28.2%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 112
Quality score 33.3%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2014 FY 2013 FY 2010 FY 2009
Revenue 7.938B 7.057B 5.706B 5.119B 4.635B 3.882B 4.307B 3.781B — — — — 1.288B 828.896M
Net profit 1.56B 1.688B 996M 737M 827M 694M 859M 792.5M — — 238.385M 14.61M 36.766M -144.093M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2014 FY 2013 FY 2010 FY 2009
Share price 143.9 258.2 196.6 — — — — — — — — — — —
Price performance 12m -0.44 0.31 — — — — — — — — — — — —

Filed figures

Figure Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (SEK) — 601M 658M 1.14B 1.27B 1.51B 1.34B
↳ YoY growth +9.5% +73.7% +11.1% +18.7% -11.3%
↳ 5y CAGR +17.3%
Other receivables (SEK) — 137M 46M 170M 180M 128M 333M
Lease liabilities (SEK) — — — — — 87M 96M
Cash and deposits (SEK) 655M 1.3B 683M 1.27B 2.14B 3.01B 2.32B
Intangible assets (SEK) — — — — — 581M 878M
Right-of-use assets (SEK) — 230M 223M 248M 207M 201M 328M
Cash flow detail
Operating cash flow (SEK) — 1.13B 998M 853M 1.61B 1.87B 1.41B
Purchases of property, plant and equipment (SEK) — -44M -42M -107M -103M -126M -91M
Purchases of intangible assets (SEK) — -91M -48M -34M -89M -112M -74M
Change in receivables (cash effect) (SEK) — 176M 54M -435M -136M -237M -96M
Change in inventories (cash effect) (SEK) — -213M -26M -26M -235M -433M -231M
Change in payables (cash effect) (SEK) — 255M -96M 348M 509M 346M -222M
Dividends paid (cash effect) (SEK) — -196M -294M -294M -343M -441M -734M
Share buybacks (cash effect) (SEK) — 0.00 -23M -16M -26M -19M -19M
Interest paid (cash effect) (SEK) — — — — -13M -15M -16M
Income taxes paid (cash effect) (SEK) — -251M -181M -141M -188M -201M -495M
Share-based compensation (SEK) — — — — — 20M 43M
Operating cash flow before change in receivables (SEK) — 950M 944M 1.29B 1.74B 2.11B 1.5B
Free cash flow (OCF - PPE - intangibles) (SEK) — 991M 908M 712M 1.42B 1.64B 1.24B
Income detail
Research and development expense (SEK) — 514M 548M 638M 653M 747M 978M
↳ 5y CAGR +13.7%
Total comprehensive income (SEK) — 606M 938M 1B 925M 1.73B 1.3B
Comprehensive income to owners (SEK) — 597M 936M 1B 929M 1.72B 1.3B
Reported — — — — — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Share

At NY CREATES, technology from Hprobe, Mycronic’s Magnetic Test business line within the Global Technologies division, is supporting more accurate and repeatable characterization of advanced magnetoresistive random access memory (MRAM) devices across research and process development.

28 OCT 2026

11:10

NEWS

GROUP

Testing as an enabler of innovation

Developing a new semiconductor technology requires more than a promising device concept. Researchers also need reliable ways to test performance, understand behavior and build the data needed for continued development.

NY CREATES is developing STT-MRAM and SOT-MRAM technologies at the device R&D and process development stages. As these technologies evolve, accurate and repeatable magnetic testing is essential, particularly when researchers need to study how devices respond to magnetic fields in different directions.

A combined magnetic and electrical test environment

To strengthen these capabilities, NY CREATES deployed Hprobe's IBEX wafer-level test platform. Hprobe is part of the Magnetic Test business line from Mycronic's Global Technologies division and develops automated test solutions for magnetic devices such as MRAM and sensors.

The IBEX platform combines precise 3D magnetic field control, high-speed electrical testing and wafer-level automation in one environment. This allows magnetic and electrical characterization to be performed together, while supporting consistent measurements across a wafer.

For NY CREATES, this has enabled more complete characterization of SOT-MRAM devices and improved confidence and repeatability in the characterization process. The platform also supports controlled magnetic-field sweeps while monitoring device resistance, providing insight into switching behavior and data retention.

“Hprobe’s IBEX system has enabled us to significantly improve the confidence and repeatability of our characterization, while making it possible to fully evaluate SOT-MRAM devices for the first time.”

Frank Tolic, Associate Vice President for Business Development, NY CREATES

From device research toward future manufacturing

Advanced testing plays an important role in developing emerging technologies. With combined magnetic and electrical characterization at wafer level, NY CREATES can support both device R&D and process development activities.

The project demonstrates how integrated magnetic and electrical testing can provide the control and repeatability required for next-generation memory technologies.

Preparing for more advanced test requirements

As MRAM technologies continue to develop, testing requirements are expanding. The ability to control magnetic field strength and angle in three dimensions supports advanced applications such as magnetic immunity testing and angle-resolved measurements. The system’s RF modules can also support ReRAM testing, extending its relevance within the wider memory-technology ecosystem.

Through Hprobe, Mycronic contributes specialized magnetic test technology designed to support development from R&D to production. The work with NY CREATES demonstrates how precise testing and automation can support the next generation of memory technologies.

Read the full success story of NY CREATES and Hprobe Mycronic here: Enabling Advanced MRAM Testing at NY CREATES with Hprobe’s IBEX Platform

Share

To all news

10/31/2026 10:31:57 PM

Watch our brief video summary of CEO and CFO comments to the Interim Report Q3 2026

Share

Today we published our Interim Report January-September 2026. "We had yet another really good quarter. We had order intake of 2.7 billion SEK, up 10 percent on a strong quarter last year", says Pierre Brorsson, CFO Senior Vice President Corporate Development.

22 OCT 2026

16:30

NEWS

GROUP

Join Anders Lindqvist, Pierre Brorsson, CFO and Senior Vice President Corporate Development, and Sven Chetkovich, Director Investor Relations, as they share their insights and perspectives in a conversation moderated by Elisa Weidlertz, Director Corporate Communications and Brand.

Read more here: https://www.mycronic.com/news-events/our-press-releases/interim-report-january-september-2026/

Share

To all news

10/31/2026 10:32:07 PM

Interim Report January-September 2026 Bull 5 Bear 0 Results

Share

22 OCT 2026

08:00

PRESS RELEASE

REGULATORY

GROUP

Third quarter

  • Order intake amounted to SEK 2,667 (2,431) million, an increase of 10 percent

  • Net sales increased 38 percent to SEK 2,356 (1,709) million. Based on constant exchange rates, net sales increased 35 percent

  • EBIT amounted to SEK 610 (255) million and the EBIT margin was 26 (15) percent

  • Earnings per share were SEK 2.41 (1.11) before and after dilution

January-September

  • Order intake amounted to SEK 8,113 (5,819) million, an increase of 39 percent

  • Net sales increased 23 percent to SEK 7,276 (5,917) million. Based on constant exchange rates, net sales increased 28 percent

  • EBIT amounted to SEK 2,245 (1,598) million and the EBIT margin was 31 (27) percent

  • Earnings per share were SEK 8.77 (6.57) before and after dilution

Outlook 2026 The Board of Directors adjusts its opinion regarding net sales for 2026, from being at a level of SEK 9.25 billion to being at a level of SEK 9.75 billion.

CEO comments Order intake in the third quarter increased 10 percent, even when compared with the strong comparable quarter last year. This was driven by High Volume and Global Technologies. Net sales increased 38 percent, driven primarily by Global Technologies , but with all divisions posting double-digit growth. In Global Technologies, the two largest business lines have a large order backlog to deliver from and the focus now is on maximizing production capacity. EBIT increased to SEK 610 million, corresponding to an EBIT margin of 26 percent, driven by a stellar development in Global Technologies.

We launched new financial targets on our Capital Markets Day on August 31, with net sales to reach SEK 20 billion by 2032-2035 and the EBIT margin to remain at current levels of around 25 percent. The sustainability targets are unchanged, as is the requirement for each division to achieve an EBIT margin above 10 percent.

Pattern Generators launched two new products during the quarter: the next generation semiconductor mask writer, SLX Kite, improving both speed and accuracy, and a semiconductor photomask inspection machine, IQX. The division received orders for one Prexision 80 Evo and two SLXs during the quarter.

ASML and TSMC announced an industry initiative during the quarter, which targets establishing a 12-inch mask pilot line by 2031, supporting advanced node production by 2033. Pattern Generators is well positioned to benefit from this technology development.

For PCB Assembly Solutions, demand continued to be tepid in the high mix-low volume segment, where PCB Assembly Solutions operates. This segment also experienced price pressure, with the weak yen enabling Japanese competitors to be aggressive on price.

For High Volume, markets outside China showed good demand, while demand from the Chinese domestic market weakened. The slowdown in China was driven by the consumer electronics industry displaying a cyclical pattern, where investments are made during the first half of the year to enable the launch of new products in the autumn.

Global Technologies had an exceptionally strong quarter, driven by product mix and volume effects, which should not be extrapolated. General market conditions for the division remained favorable, driven by AI infrastructure, advanced packaging and defense investments. In PCB Test’s market, PCB manufacturers continued to increase their investments. The Die Bonding business line also saw healthy demand, driven by AI infrastructure investments and aerospace & defense.

On a final note, I would like to thank Charlott Samuelsson, who is retiring as Senior Vice President Pattern Generators, for her invaluable contributions to Mycronic throughout nearly an entire professional career and wish her every success as she enters the next phase of her life. At the same time, I am delighted and confident to welcome Mikael Wahlsten as the new Senior Vice President Pattern Generators and member of the Executive Management team. Mikael possesses exceptional expertise, with both extensive breadth and deep knowledge of Pattern Generators’ business, and is the ideal person to lead the continued development of the division.

Anders Lindqvist, President and CEO

Financial information Mycronic AB (publ) is listed on Nasdaq Stockholm, Large Cap. The information in this report is published in accordance with the EU Market Abuse Regulation and the Swedish Securities Act. The information was submitted for publication, through the contact persons stated below, at 8:00 a.m. CEST on October 22, 2026.

Financial reports and press releases are published in Swedish and English and are available at mycronic.com.

This report was reviewed by the company’s auditor.

Presentation Mycronic will hold a presentation at 10:00 a.m. CEST on October 22, 2026, with President and CEO Anders Lindqvist and CFO and Sr VP Corporate Development Pierre Brorsson. The presentation will be webcast.

For additional information, please contact: Anders Lindqvist President and CEO Tel: +46 8 638 52 00 E-mail: [email protected]

Pierre Brorsson CFO & Sr VP Corporate Development Tel: +46 8 638 52 00 E-mail: [email protected]

Sven Chetkovich Director Investor Relations Tel: +46 70 558 39 19 E-mail: [email protected]

Prompts

Mycronic (ticker MYCR), listed in Sweden.

ETFs Holding Mycronic

ETF Weight in ETF Shares Market value As of
SEIE 0.21% 73,364 $ 2.435M Jun 30, 2026
JSTC 0.11% 11,025 $ 315.58K Nov 17, 2026
AVDE 0.05% 356,620 $ 10.138M Nov 16, 2026
DFSI 0.04% 16,849 $ 499.559K Nov 12, 2026
AVSD 0.03% 4,337 $ 123.298K Nov 16, 2026
DFIC 0.03% 142,775 $ 4.233M Nov 12, 2026
DFAX 0.02% 87,218 $ 2.586M Nov 12, 2026
DFAI 0.02% 114,515 $ 3.395M Nov 12, 2026
AVDS 0.01% 1,462 $ 41.564K Nov 16, 2026
DIHP 0.01% 18,485 $ 548.065K Nov 12, 2026
DXIV 0.00% 170 $ 5,040.36 Nov 12, 2026